How Important Is Keytruda For Merck?

August 30, 2019   |   August 2019 Bond Updates
Merck’s (NYSE:MRK) Keytruda is its top selling drug with sales of over $7 billion in 2018. Keytruda is used for the treatment of different types of cancers, including lung, head & neck, and melanoma among others. It has become the most important drug for Merck, given its contribution to the compa...

View more at: https://www.forbes.com/sites/greatspeculations/2019/08/29/how-important-is-keytruda-for-merck/
 
Related News
Home| About us | Contact us http://www.bondupdatesdailynews.com/